| Systematic (IUPAC) name | |
|---|---|
| 3-(2-Diethylaminoethyl)-1H-indol-4-yl acetate | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| ATC code | ? |
| ChemSpider | 21106239 |
| Chemical data | |
| Formula | C16H22N2O2 |
| Mol. mass | 274.36 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
4-Acetoxy-DET (4-Acetoxy-N,N-diethyltryptamine), also known as ethacetin, ethylacybin or 4-AcO-DET is a hallucinogenic tryptamine. It was first synthesized in 1958 by Albert Hofmann in the Sandoz lab.[1]
It is expected that the compound is quickly hydrolyzed into the free phenolic 4-HO-DET by serum esterases, but human studies concerning the metabolic fate of this drug are lacking.
|
Contents
|
4-Acetoxy-DET is orally active, and dosages of 10–25 mg are common. Effects last 4–6 hours.[2] The free base is also active when smoked in a dose range of 5–20 mg.[1] Smoking 4-acetoxy-DET greatly speeds up the onset; peak effects are experienced within 10 minutes, and are usually over within 1 hour.[specify]
4-Acetoxy-DET is unscheduled in the United States, but possession and sales of 4-Acetoxy-DET could possibly be prosecuted under the Federal Analog Act if intent to consume can be proven because of its structural similarities to DET.
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)